|
|
Volumn 8, Issue 4, 2013, Pages 319-331
|
|
Clinical pharmacokinetics of retigabine/ezogabine.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICONVULSIVE AGENT;
CARBAMIC ACID DERIVATIVE;
PHENYLENEDIAMINE DERIVATIVE;
RETIGABINE;
AGE;
AGED;
BIOAVAILABILITY;
CLINICAL TRIAL (TOPIC);
DOSE RESPONSE;
DRUG INTERACTION;
FOCAL EPILEPSY;
HALF LIFE TIME;
HUMAN;
KIDNEY FAILURE;
LIVER DISEASE;
PATHOPHYSIOLOGY;
REVIEW;
AGE FACTORS;
AGED;
ANTICONVULSANTS;
BIOLOGICAL AVAILABILITY;
CARBAMATES;
CLINICAL TRIALS AS TOPIC;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
EPILEPSIES, PARTIAL;
HALF-LIFE;
HUMANS;
LIVER DISEASES;
PHENYLENEDIAMINES;
RENAL INSUFFICIENCY;
MLCS;
MLOWN;
|
|
EID: 84906933443
PISSN: None
EISSN: 22123938
Source Type: Journal
DOI: 10.2174/15748847113089990053 Document Type: Review |
|
Times cited : (25)
|
|
References (0)
|
